Rochester, Minnesota — According to state and local development sources, Nucleus RadioPharma plans to build out 10,000 square feet of new space in Rochester. The company plans to occupy the new space in Rochester, on or about June 1, 2024. According to the company website Nucleus RadioPharma is a full-service Contract Development and Manufacturing Organization (CDMO) dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies. We are building our development and manufacturing facilities in proximity to prominent destination medical centers and key distribution hubs. Nucleus relationships will enable access to the worlds largest radiopharmaceutical clinical trial networks and provide timely delivery of short half-life theranostics products to patients. Our technology platforms and drug development expertise provide clients with end-to-end support including formulation and analytical development, regulatory documentation, drug product manufacturing, and distribution to patients. Innovators can come to us at any point in their product lifecycle and receive the optimal services that rapidly advance their program. Our CDMO services are flexible with multiple onboarding points, designed to expand in line with future demand.

To learn more about Nucleus RadioPharma, visit http://nucleusrad.com/

Company Contact:
Charles Conroy, Chief Executive Officer
https://www.linkedin.com/in/charlesconroyrph/
407-988-4119

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.